Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Targeting skeletal endothelium to ameliorate bone loss.
Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself.
CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species.
CpG oligonucleotides protect against Venezuelan equine encephalitis virus infection in a route-dependent manner.
Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation.
See All 12 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation.
Wang Y, Krieg AM. Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation. Int Immunol. 2003 Feb; 15(2):223-31.
View in:
PubMed
subject areas
Animals
B-Lymphocytes
Cell Division
CpG Islands
DNA
Mice
Mice, Inbred C57BL
Muramidase
authors with profiles
Arthur M Krieg MD